COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 102: Articles 1011-1020  | Next

Dissecting serum polyclonal antibody escape to SARS-CoV-2 variants by deep mutational learning
Shlesinger, D., Sadilek, V., Minot, M., Stamkopoulos, E., Bikias, T., Kuhn, R., Agrafiotis, A., Taft, J. M., Yermanos, A., Reddy, S. T.
10.1101/2025.05.01.651552 — Posted: 2025-05-02
Modeling epithelial and endothelial cell tropism for SARS-CoV-2 through restricted transgenic hACE2 expression in mice
Lameire, S., Debeuf, N., Deckers, J., De Wolf, C., Vanheerswynghels, M., Toussaint, W., De Vlieger, L., Van Hoecke, L., De Cae, S., Schepens, B., Vanhee, S., Lambrecht, B. N.
10.1101/2025.05.01.651662 — Posted: 2025-05-02
Expression and Characterization of SARS-CoV-2 Spike Protein in Thermothelomyces heterothallica C1
Ophir, Y., Wong, J., Haddad, K. R., Huuskonen, A., Karmaker, A., Gore, V., Jung, S., Oloumi, A., Liu, Y., Fu, J., Zhang, L., Huang, P., Minami, S. A., Garimella, S. S., Thyagatur, A., Zaini, P. A., Vitikainen, M., Tchelet, R., Valbuena, N., Fuerst, T., Korkmaz, E., Falo, L. D., Balmert, S. C., Mahendiratta, S., Emalfarb, M., Shah, P., Siegel, J. B., Dandekar, A. M., Chen, X., Lebrilla, C. B., Faller, R., Saloheimo, M., McDonald, K. A., Nandi, S.
10.1101/2025.05.01.651343 — Posted: 2025-05-02
Experiences of accessing primary care by those living with long Covid in New Zealand.
Rhodes, S., Douglas, C.
10.1101/2025.04.29.25326651 — Posted: 2025-05-01
Navigating Life After COVID-19: Adoption of Preventive Behaviour Among Citizens Post-Pandemic
Dong, Y., Wong, C. H., SPR, C. R., Paraman, P.
10.1101/2025.04.29.25326653 — Posted: 2025-05-01
Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study
Humphreys, J., Nicolay, N., Braeye, T., Van Evercooren, I., Holm Hansen, C., Rask Moustsen-Helms, I., Sacco, C., Fabiani, M., Castilla, J., Martinez-Baz, I., Machado, A., Soares, P., Ljung, R., Pihlstrom, N., Kissling, E., Nardone, A., Monge, S., Bacci, S., Nunes, B., VEBIS-EHR working group
10.1101/2025.04.30.25326709 — Posted: 2025-05-01
A Tale of Three (Major) Cities: Trends in Covid-19 Firearm Deaths Pre- vs. Post-Pandemic
Cardone, C., Kilpatrick, A., Bunker, S., Ledet, R., Duran, M., Coello-Sanchez, C., D'Amico, M., Richman, M.
10.1101/2025.04.28.25326367 — Posted: 2025-05-01
Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1
Guo, C., Yu, Y., Liu, J., Jian, F., Yang, S., Song, W., Shao, F., Yu, L., Cao, Y.
10.1101/2025.04.30.651462 — Posted: 2025-05-01
RECUR: Identifying recurrent amino acid substitutions from multiple sequence alignments
Robbins, E. H., Liu, Y., Kelly, S.
10.1101/2025.04.29.651261 — Posted: 2025-04-30
Kozak sequence libraries for characterizing transgenes across expression levels
Shukla, N., Kamath, N. D., Snell, J. C., Bruchez, A. M., Matreyek, K. A.
10.1101/2025.04.28.651141 — Posted: 2025-04-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).